LabCorp 2015 Annual Report Download - page 38

Download and view the complete annual report

Please find page 38 of the 2015 LabCorp annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 151

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151

Index
lower than the Company expects and may take longer to achieve than anticipated, and expenses may be higher than the Company expects. The Company has
made certain assumptions relating to the Acquisition and integration that may prove to be materially inaccurate, including:
the Companys assessments of the asset quality and value of Covance and its assets;
projections of the business and CDD's future financial performance;
timing and total costs of integrating a large number of processes, policies, procedures, operations, technologies and systems;
the Companys ability to realize synergies and the timeline for doing so;
the Companys ability to develop, maintain and deepen relationships with CDD's customers; and
other financial and strategic risks of the Acquisition.
If one or more of these assumptions are incorrect, it could have a material adverse effect on the Company’s business and operating results, and the value of
its common stock may be adversely affected.
In addition, although CDD is subject to many of the same risks and uncertainties that the Company faces in its business, the acquisition of Covance also
involves the Company entering new product and services areas, markets and industries, which presents risks resulting from the Company’s relative
inexperience in these new areas. CDD’s business could react differently to economic and other external factors than the Companys. The Company faces the
risk that it will not be successful with these new products and services or in these new markets.

None.
38